Trials / Conditions / Extramedullary Multiple Myeloma

Extramedullary Multiple Myeloma

3 registered clinical trials studyying Extramedullary Multiple Myeloma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With NCT06793475	Institute of Hematology & Blood Diseases Hospital, China	N/A
Recruiting	Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Mainten NCT06140966	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2
Unknown	A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refract NCT05201118	Chunrui Li	Phase 1